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Beclin-1Herp is an endoplasmic reticulum (ER) stress inducible protein that participates in the ER-associated protein
degradation (ERAD) pathway. However, the contribution of Herp to other protein degradation pathways like
autophagy and its connection to other types of stress responses remain unknown. Here we report that Herp
regulates autophagy to clear poly-ubiquitin (poly-Ub) protein aggregates. Proteasome inhibition and glucose
starvation (GS) led to a high level of poly-Ub protein aggregation thatwas drastically reduced by stably knocking
down Herp (shHerp cells). The enhanced removal of poly-Ub inclusions protected cells from death caused by
glucose starvation. Under basal conditions and increasingly after stress, higher LC3-II levels and GFP-LC3 puncta
were observed in shHerp cells compared to control cells. Herp knockout cells displayed basal up-regulation of
two essential autophagy regulators—Atg5 and Beclin-1, leading to increased autophagic ﬂux. Beclin-1 up-
regulation was due to a reduction in Hrd1 dependent proteasomal degradation, and not at transcriptional
level. The consequent higher autophagic ﬂux was necessary for the clearance of aggregates and for cell survival.
We conclude that Herp operates as a relevant factor in the defense against glucose starvation by modulating
autophagy levels. These data may have important implications due to the known up-regulation of Herp in
pathological states such as brain and heart ischemia, both conditions associated to acute nutritional stress.
© 2013 Elsevier B.V. All rights reserved.1. Introduction
The endoplasmic reticulum (ER) is a specialized compartment for
the sequential folding and quality control of proteins trafﬁcking through
the secretory pathway. Any alteration compromising ER homeostasis
affects this function and triggers an adaptive mechanism known as the
unfolded protein response (UPR), which attenuates stress levels by
diverse strategies [1–4]. The UPR controls the expression of several
ER chaperones and foldases, it attenuates general translation and
also enhances protein quality control mechanisms including theSciences, Faculty of Medicine,
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d.uchile.cl (C. Hetz),
du (S. Lavandero).
ights reserved.degradation of abnormally folded proteins through the ER-associated
protein degradation (ERAD) pathway and macroautophagy, to which
we refer here as autophagy [3].
Autophagy consists of the sequestration of cytosolic components
including proteins and organelles into double membrane vesicles called
autophagosomes. These vesicles fuse with lysosomes, where their cargo
is degraded for further recycling. Autophagy is controlled by the ATG
family of genes, a group of evolutionary conserved and essential
proteins that regulate different steps of this catabolic pathway [5].
Two members of this family are Atg5 and Beclin-1. Atg5 regulates the
expansion of nascent autophagophores and the processing of LC3.
Beclin-1 on the other hand, is a positive regulator of the class-
III phosphatidylinositol 3-kinase (PI3K-III) complex that catalyzes
phagophore elongation and autophagosome formation [6]. Activation
of autophagy is essential for cell survival under nutrient deprivation,
but increasing evidence indicates that autophagy is a relevant factor
against different forms of cell stress as well [7]. During ER stress, the
autophagic pathway degrades ER and attenuates the harmful effect of
unfolded protein accumulation. Because it assists ERAD when it is
impaired, autophagy has been referred to as an ERAD II pathway [8,9].
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membrane spanning protein that is strongly upregulated during ER
stress. Both Herp and its yeast ortholog Usa1p are part of the ERAD
pathway [10,11]. Herp has an N-terminal ubiquitin (Ub)-like domain
(ULD), and mediates the degradation of proteins through interactions
with the ERAD machinery [12–14]. It has been shown that Herp, like
Usa1p, complexes with the E3-ubiquitin ligase Hrd1, favoring the
ubiquitination and degradation of α1-antitrypsin NHK [13]. Despite
the well-established role of Herp in the ERAD pathway, little is known
about its role as an UPR responsive gene, and its functions may lay
further than as an ERAD modulator, possibly due to the function of its
target substrates. There is evidence—mainly from neuronal models—
that Herp protects from apoptosis during ER stress by preventing loss
of mitochondrial potential, preventing caspase activation, the induction
of CHOP and the activation of JNK [15,16]. A recent report indicated the
unexpected ﬁnding that reducing Herp levels can promote the
degradation of cytosolic protein aggregates containing α-synuclein or
synphilin-1 by an alternative unclear mechanism [17], thus extending
the role of Herp to other degradation mechanisms than the ERAD.
Moreover, Herp interacts with several other proteins involved in
degradative mechanisms such as ubiquilins [12] and has been shown
to promote an increase of Aβ-amyloid peptides through its interaction
with presenilins [18]. Accumulation of abnormal protein aggregates is
linked to the occurrence of several neurodegenerative diseases [19]
where induction of autophagy is proposed to have a beneﬁcial activity
through the removal of abnormally folded proteins [20]. Interestingly,
another recent report shows that Herp deﬁciency in mice leads to
glucose intolerance [21]. However, there are no further reports studying
the functions that Herp may have in regulating autophagy.
Here we studied the role of Herp under different stress conditions
associated to pathological protein accumulation. In particular, we
observed that Herp depletion increases autophagic ﬂux through the
up-regulation of Beclin-1 and Atg5, and this mechanism prevents cell
death induced by glucose deprivation. We demonstrate that Beclin-1
up-regulation in Herp-depleted cells was not due to increased
transcription of the BECN1 gene, but to reduced proteasomal
degradation instead. This set of data indicates that Herp acts as an
important regulator not only of the ERAD pathway but also of
autophagy, both of them essential protein degradation pathways.
2. Materials and methods
2.1. Reagents
Dulbecco's modiﬁed Eagle's medium (DMEM), Earle's Balanced Salt
Solution medium, propidium iodide, Triton X-100, EDTA, 3-MA,
baﬁlomycin-A1, E64D, pepstatin A, anti-β-actin, and anti-β-tubulin
antibodies were purchased from Sigma-Aldrich Co. (St. Louis, MO,
USA). Secondary anti-mouse and rabbit antibodies and MG132 were
obtained from Calbiochem (Burlington, ON, Canada). Fetal Bovine
Serum (FBS), Optimem, trypsin, RPMI Medium 1640, L-glutamine,
non-essential amino acids, HEPES, EDTA and penicillin/streptomycin
were purchased from GIBCO (Paisley, Scotland, UK). MTT (3-(4,5-
dimetiltiazol-2-il)-2,5-difeniltetrazolium), 3,3′dihexyloxacarbocyanine
iodide (DiOC6(3)), Lipofectamine 2000, Oligofectamine, Hoechst, and
Alexa Fluorine 488 and 568 antibodieswere from Invitrogen (Molecular
Probes-Invitrogen, Carlsbad, CA, USA). Tunicamycin, thapsigargin,
puromycin and anti-Herp were from BIOMOL Research Laboratories
(Plymouth Meeting, Pennsylvania, USA). Antibodies for phospho-
eIF2α and LC3 were from Cell Signaling Technology (Danvers, MA,
USA). Anti-CHOP, anti-JNK, phospho-JNK, anti-Beclin-1, anti-Bcl-2,
anti-Ub and anti-BiP antibodies were from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Anti-Hrd1 antibody and Hrd1 siRNA were from
Sigma-Aldrich. All the materials for SDS-PAGE, nitrocellulose and
PVDFmembraneswere purchased fromBio-Rad Laboratories (Hercules,
CA, USA). Fluorescence mounting medium was obtained from DAKOCorporation (CA, USA). Organic and inorganic compounds, acids and
solvents were acquired fromMerck (Darmstadt, Germany). SuperSignal
West Pico chemiluminescent substrate was obtained from Pierce
(Rockford, IL USA).
2.2. Cell lines, culture conditions and treatment
HeLa, U20S, HEK293T cells and MEFs were cultured in DMEM
supplemented with 10% FBS and 100 units/ml penicillin G sodium and
100 μg/ml streptomycin sulfate at 37 °C under 5% CO2. MEF cells were
supplemented with 5 mM L-glutamine and 10 mM HEPES buffer. For
amino acid and glucose starvation, cells were cultured in serum-free
Earle's Balanced Salt Solution medium (AS) or RPMI Medium 1640
without glucose (GS), respectively.
2.3. Western blot
ForWestern blot analysis, 1×106cells were washed with PBS at 4°C
and lysed with RIPA buffer (20mM Tris, 150mM NaCl, 0.1% SDS, 0.5%
DOC, 0.5% Triton X-100, pH 8.0), followed by 3 min of sonication.
Total protein concentration was determined by the Bradford assay.
Equal protein amounts (20–50 μg) were loaded on 8–15% SDS–
polyacrylamide gels. Proteins were electrotransferred to nitrocellulose
or PVDF membranes using a semi-dry apparatus. Blocking was
performed in 5% milk in PBS–Tween-20 (0.05%) for 1 h. Primary
antibodies, anti-Herp, anti-Beclin1, anti-ubiquitin, anti-CHOP or anti-
BiP, were incubated overnight at 4 °C and the appropriate horseradish
peroxidase-conjugated secondary antibodies and the SuperSignal
West Pico chemiluminescent substrate were used for imaging. Anti β-
tubulin or GAPDH was used as loading control. Quantitative
immunoblot analysis was carried out using Un-Scan-It software (Silk
Scientiﬁc, Inc. Utah, USA).
2.4. Lentivirus and the production of stable knockdown cells
HEK293T cells were transfected in Optimem medium with
Lipofectamine 2000 according to the manufacturer's instructions,
using the following plasmids: VSV-G, pMDL, REV and PLKO.1-shHerp
or PLKO.1-shLuc. After 48 h, the conditioned medium with lentiviral
particles was collected and ﬁltered with 0.45 μm pore diameter ﬁlters.
HeLa, HEK293T, HeLa GFP-LC3 or U20S GFP-LC3 cells were incubated
with conditioned medium. After 48 h of viral transduction, medium
containing 2 μg/ml puromycin was used for the selection process of
shHerp and shLuc cells.
2.5. Cell survival assays and ﬂow cytometry
Cell viability was determined by measuring (a) incorporation of
the vital dye propidium iodide (PI; 1 μg/ml); (b) reduction of the
mitochondrial transmembrane potential (ΔΨm) with 40 nM DiOC6(3)
staining; (c) the reduction of MTT to the colored compound formazan
and (d) the percentage of cells with subG1 fragmented DNA using PI
staining. DiOC6(3) and PI ﬂuorescence were quantiﬁed with a ﬂow
cytometer (Becton Dickinson, San Jose, USA). Analysis of GFPμ or CD3-
YFP for the reporter activity of proteasomal degradation or ERAD
respectively, was performed using cells 24h after transient transfection
of the reporters. A ﬂow cytometer (Becton Dickinson, San Jose, USA)
was used for ﬂuorescence quantiﬁcation on singlets of live cells gated
on FSC/SSC.
2.6. Immunoﬂuorescence
Cells were ﬁxed in paraformaldehyde (4% w/v) and incubated
overnight at 4 °C with LC3 or ubiquitin antibodies, and revealed with
Alexa® Fluor conjugates. For immunostained cells, or GFP-expressing
ﬁxed cells, nuclei were labeled with 10 μg/ml Hoechst 33342.
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equipped with a DC300F camera. Confocal microscopy was performed
using a Zeiss LSM 510 microscope equipped with a 63× objective.
2.7. Statistical analyses
Data are expressed as the average±SEM of at least 3 independent
experiments. ⁎p b 0.05; ⁎⁎p b 0.01; and ⁎⁎⁎p b 0.001 denote statistical
signiﬁcances vs. non-treated controls. ‡p b 0.05; ‡‡p b 0.01; and
‡‡‡p b 0.001 denote statistical signiﬁcance vs. equally-treated cells
with different genetic proﬁle. Statistical analyses were carried out
with GraphPad InStat software by means of ANOVA or t-test, and
comparisons among groups were carried out using the test of Tukey.‡‡‡
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Fig. 1. Effect of ER stress on Herp expression and cell viability. (a) Mouse embryonic ﬁbroblast
protein levels were analyzed by Western blot. Images are representative of 3 independent exp
times. HerpmRNA levels were determined with qPCR and normalized to β-actinmRNA levels. (
vectors (shHerp and shLuc) were treated with Tm (1μg/ml) for the indicated times; Herp and B
cells were treatedwith Tm for 48h at the indicated concentrations and viability was studied by
(d), MTT reduction assay (e), propidium iodide (PI, 1μg/ml) incorporation (f) and DNA fragmen
as mean ± SEM of at least 3 independent experiments. Statistical signiﬁcance was calculated
⁎⁎p b 0.01; ⁎⁎⁎p b 0.001 vs. control. ‡p b 0.05; ‡‡p b 0.01; ‡‡‡p b 0.001 between shLuc and shHer3. Results
3.1. Herp deﬁciency modulates cell death during early stress conditions
Tunicamycin (Tm) blocks early protein synthesis by inhibiting N-
linked peptidic glycosylation and is a classical trigger of ER stress.
Mouse embryonic ﬁbroblasts (MEFs) were treated for 6 h with Tm at
different concentrations and the protein levels of Herp, in addition to
the classical ER stressmarkers CHOP and eIF2α or JNK phosphorylation,
were determined by Western blot (Fig. 1a). Induction of all ER stress
markers was observed as expected, but there was also a strong increase
in Herp protein levels (Fig. 1a). To assess whether this effect on Herp
was transcriptional, we measured herp mRNA levels not only in these0
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measuring the reduction ofmitochondrial transmembrane potential (ΔΨm)with DiOC6(3)
tation through subG1 DNA content (g), where Tmwas used at 1μg/ml. Data are expressed
using ANOVA and group comparisons were determined with the Tukey test. ⁎p b 0.05;
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with Tm signiﬁcantly increased herp mRNA levels and that was
dependent on IRE1α (Fig. 1b). Herp mRNA levels were 34-fold higher
in IRE1α-WT cells than in IRE1α-KO cells treated for 8 h with Tm.
Considering these results, we studied the role of Herp in detail using a
knock-down setting. We generated HeLa stable cell lines with lentiviral
vectors encoding a Herp-speciﬁc shRNA construct (shHerp), or an
unrelated shRNA (shLuc). In shHerp cells, the induction of Herp by ER-
stress was abolished, and the levels of the ER stress marker GRP78/BiP
were reduced (Fig. 1c). To discard possible artifacts associated to the
cell-selection process, we performed transient siRNA transfection and
observed similar results (Supplementary Fig. 1a). To study the
involvement of Herp in the cell death response to ER stress we used
four different methods. Signiﬁcant differences were observed between
shLuc and shHerp cells subjected to 1 μg/ml Tm when we evaluated
early stages of cell death, such as the reduction of the mitochondrial
transmembrane potential (ΔΨm, Fig. 1d) and the loss in reductive
power throughMTT reduction assays (Fig. 1e). However, no differences
were detected when we evaluated late stage death indicators such as
incorporation of the vital dye propidium iodide (PI) or DNA
fragmentation through subG1 analysis (Fig. 1f and g).
While tunicamycin-induced ER stress is triggered by abnormal
protein folding in the ER lumen, this does not necessarily correlate
with spontaneous aggregation of damaged or long-lived proteins. To
trigger accumulation of ubiquitinated protein aggregates we inhibited
proteasomal protein degradation withMG132. After MG132 treatment,
a strong increase in Herp protein levels was observed in control shLuc
cells, but not in shHerp cells (Fig. 2a). Immunoﬂuorescence experiments
showed an early increase in poly-Ub proteins in shLuc cells subjected to
proteasome inhibition (Fig. 2b). Unexpectedly, knocking down Herp
drastically reduced the accumulation of poly-Ub protein inclusions
induced byMG132 treatment (Fig. 2b). Again here, we observed similar
results using a transient siRNA-mediated knockdown of Herp
(Supplementary Fig. 1b). Next, we performed Western blot to measure
poly-Ub accumulation. In accordance with the above results, weshLuc shHerp
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quantiﬁed using ANOVA, and group comparisons were determined using the Tukey test. ⁎p b 0observed that the knockdown of Herp reduced the poly-Ub signal
after MG132 (Fig. 2c). To ﬁnd out if this effect was compartmented in
the cytosol or the nucleus, we used subcellular fractions and observed
consistently that both fractions showed less poly-Ub accumulation in
shHerp cells (Supplementary Fig. 2). These data strongly suggest that
absence of Herp leads to increased clearance of poly-Ub aggregates. To
study if this has an impact on cell survival, we studied the inﬂuence of
proteasome inhibition on the viability of shHerp and shLuc cells. In
contrast to the effects observed in cells treated with Tm, knocking
down Herp protected cells against reduction of ΔΨm induced by
MG132 (Fig. 2d), without an impact on endpoint cell death responses
(Fig. 2e and f). Altogether, these results suggest that a reduction in
Herp levels may activate protective mechanisms that correlate with
decreased accumulation of poly-Ub proteins.
3.2. A reduction in Herp levels protects cells from acute glucose starvation
Based on the above results we decided to study the role of Herp
using an acute stress condition such as nutrient deprivation, which is
normally observed during short periods of ischemia [22]. We subjected
cells to glucose and amino acid starvation (GS and AS, respectively) and
observed an increase in Herp levels after GS, but interestingly, not after
AS (Fig. 3a). Next, we studied whether the absence of Herp affects
protein aggregation during glucose starvation. We observed a decrease
in poly-Ub aggregation on GS treated shHerp cells (Fig. 3b) and similar
resultswere obtained using transientHerp knockdown (Supplementary
Fig. 3a). Then, we determined the deleterious effect of GS under Herp
depletion conditions. Remarkably, we observed that Herp knockdown
abrogated the negative effects of GS on the reduction of ΔΨm (Fig. 3c).
In addition, PI-incorporation and DNA fragmentation through subG1
analysis were signiﬁcantly reduced in shHerp cells subjected to GS
(Fig. 3d and e), but not to AS (Supplementary Fig. 3b), which agrees
with the above observation that only GS, but not AS, augments Herp
levels (Fig. 3a). All these data suggest that, under acute glucose
starvation, a reduction in Herp levels could trigger or unlocknsns
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susceptibility to cell death.
3.3. Herp depletion activates protective autophagy and poly-Ub clearance
Autophagy plays a major role in the clearance of damaged proteins,
as well as in the regulation of the cellular nutritional status. Our
observations that Herp depletion rescues from poly-Ub aggregation
during glucose starvation prompted us to evaluate autophagy in this
response.We pre-incubated shHerp and shLuc cells with the autophagy
inhibitor 3-methyladenine (3-MA), which blocks autophagosome
formation via inhibition of the PI3K-III complex. After 2 h of GS, we
observed a clear increase in poly-Ub aggregates in shLuc cells, which
was only evident in shHerp cells when autophagy was inhibited with
3-MA (Fig. 4a). To validate that autophagy was indeed taking course
in shHerp cells during GS, we monitored the processing of endogenous
LC3 by Western blot as well as the formation of autophagic puncta by
confocal microscopy. We observed that GS stimulated higher and faster
LC3 processing in shHerp cells than shLuc cells (Fig. 4b). Confocal
microscopy studies revealed similar results showing that shHerp cells
displayed higher GFP-LC3 autophagic puncta (Fig. 4c). Immuno-
ﬂuorescence against endogenous LC3 revealed equivalent results
(Supplementary Fig. 4a). To discard artifacts due to cell line in use, we
generated stable HEK293T cells with the shLuc and shHerp constructs,
and obtained similar results (Supplementary Fig. 4b). These results
conﬁrmed—using independent cellular settings—that Herp depletion
enhances autophagy even at steady-state conditions.
An increase in LC3-II levels, or in autophagic puncta can result not
only from augmented autophagosome formation (positive autophagic
ﬂux), but also from decreased lysosomal degradation of auto-
phagosomes (impaired autophagic ﬂux). To discriminate between the
two possibilities, the currently validated strategies consist of measuring
autophagic parameters in the additional presence of lysosomal
inhibitors [23,24]. We used baﬁlomycin-A (Baf-A), which inhibits the
lysosomal vacuolar type H+-ATPase, rising lysosomal pH and impairing
the fusion of autophagosomes with lysosomes. Under basal conditions,
lysosomal inhibition with Baf-A led to a higher accumulation of
autophagosomes in shHerp cells compared to shLuc cells (Fig. 4d). In
addition, we measured the degradation of GFP-LC3 by Western blot,
which is a lysosomal endpoint of autophagic ﬂux. We observed that
under basal conditions, GFP levels were lower in shHerp cells, and this
was more pronounced after glucose starvation (Fig. 4e), conﬁrming
that shHerp cells have increased autophagic ﬂux. Next, we studied
whether inhibition of autophagic ﬂux has any impact on Herp-
mediated protection to GS. We measured ΔΨm, and observed that
treatment with Baf-A decreased the protective effect of Herp depletion
on GS treated cells (Fig. 4f). Altogether, these data indicate that
depletion of Herp levels increases basal autophagic ﬂux, and this
contributes to eliminate poly-Ub aggregates under GS conditions,
hence protecting from cell death. This suggests that Herp might have a
repressor role for autophagy under the evaluated conditions.
3.4. Herp regulates Beclin-1 levels post-translationally
Based on the above data showing up-regulation of autophagy in the
absence of Herp, we measured the levels on essential autophagy
regulators in these cells. Beclin-1 is a key protein catalyzing the early
stages of autophagosome formation. In agreement with our previous
results, we observed that stable Herp knockdown cells have higher
basal levels of Beclin-1 (Fig. 5a). Similar results were observed when
we used transient siRNA-mediated knockdown of Herp (Fig. 5b).
Under these conditions, we studied the levels of another essential
regulator of autophagosome nucleation—Atg5 and observed similar
results (Fig. 5b). We corroborated the above data using another
human cell line, HEK293T, and observed a consistent up-regulation of
Beclin-1 after stable Herp knockdown (Supplementary Fig. 4c). In
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scriptional level, we performed qPCR experiments and observed that
interestingly, both BECN1 and ATG5 mRNA levels were dramatically
reduced in shHerp cells (Fig. 5c). Because Herp has an ubiquitin-
binding domain, this data suggests that Herp may affect the levels of
these proteins post-translationally. To ﬁnd out this possibility we
treated shLuc and shHerp cells with the proteasome inhibitor MG132
andmeasured the protein levels of Beclin-1. Only shLuc cells responded
to MG132 treatment by accumulating Beclin-1 levels, whereas in
shHerp cells there was no effect on Beclin-1 accumulation (Fig. 5d). Of
note, Herp levels were clearly increased after MG132 in control cells,
which is consistent with the short half-life described for this protein
[25]. To validate that Herp depletion affects proteasomal degradation
we used ﬂow cytometry to measure the levels of GFPμ and CD3-YFP.
GFPμ is a speciﬁc Ub-proteasome system reporter, while CD3-YFP is aspeciﬁc ERAD reporter [9,26]. We observed that both reporters showed
accumulated levels in shHerp cells (Fig. 5e and f), conﬁrming that not
only ERAD but also proteasomal degradation is impaired in these cells.
To investigate themechanismbehindBeclin-1 accumulationwe studied
the role of Hrd1. Herp interacts with the E3 ubiquitin ligase Hrd1.
Absence of Hrd1 by transient siRNA transfection (Fig. 5g) led to an
accumulation of Beclin-1 levels in control shLuc cells, but this effect
was reduced in shHerp cells (Fig. 5h), indicating that in the absence of
Herp, the effects of Hrd1 on Beclin-1 degradation are lost. This sets
Herp and Hrd1 in the mechanism that links Beclin-1 ubiquitination for
its proteasomal degradation. Altogether, the results from this study
indicate that Herp is an endogenous inhibitor of autophagy. Herp
depletion contributes to stabilize Beclin-1 levels and the autophagic
response to GS, increasing the clearance of poly-Ub proteins and
protecting from cell death.
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Fig. 6.Herp controls the balance between the ERAD pathway of proteasomal degradation
and the autophagy/lysosomal degradation pathway. Left panel: glucose deprivation
triggers the accumulation of poly-ubiquitinated (poly-Ub) protein aggregates. Herp
mediates the proteasomal degradation of these aggregates and also that of the autophagy
regulator Beclin-1. This keeps Beclin-1 in a balanced statewhere itmaintains autophagy at
basal levels. Right panel: Absence of Herp (by depletion or possibly inhibition) leads
to decreased Beclin-1 proteasomal degradation, which unleashes a compensatory
autophagic response that contributes to clear poly-Ub aggregates. Herp therefore, is a
stress integrator coordinating the balance between two degradative mechanisms that
operate under glucose starvation conditions, regulating the balance of life–death cellular
outcomes.
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Over the past two decades, ER stress has emerged as a central
player in human pathology. Metabolic diseases, immune disorders,
neurodegeneration, and ﬁbrosis of the liver, lungs or the heart,
constitute just a few examples [27]. Experimentally, ER stress is
commonly triggered by alterations in protein synthesis andmaturation,
which leads to accumulation of misfolded proteins. However,
impairment in protein degradation also affects the ER synthetic
efﬁciency and triggers this response [3]. On the other hand, a decrease
in ATP levels due to glucose starvation impairs oligosaccharide-
associated protein synthesis, and is increasingly viewed as a cause of
ER stress as well. Depending on the intensity, duration, and nature of
the stimuli, UPR signaling can result in the engagement of multiple
adaptive processes (i.e. folding, ERAD and autophagy) or the induction
of cell death programs [1,3]. However, the mechanisms underlying
this transition between chronic to an irreversible stress response are
not well understood, and represent an essential point of intervention
for controlling cell fate [3].
In this study, we used several types of cellular stress to emulate
pathological conditions where ER stress and protein misfolding are
involved, and focused our attention on the role of Herp using diverse
stress stimuli, including classical ER stressors, proteasome inhibition
and nutrient starvation. While all these conditions culminate in Herp
up-regulation, depletion of Herp has a protective role that rescues
fromglucose starvation only. Under acute glucose starvation conditions,
we observed an increase in poly-Ub proteins, which was markedly
reduced in Herp-depleted cells. Interestingly, the role of Herp in
mediating protectionwas associated to an increment on the basal levels
of the essential autophagy regulators Atg5 and Beclin-1, leading to
increased autophagic ﬂux and facilitating the clearance of poly-Ub
protein aggregates. As a consequence, ΔΨm was stabilized as an early
response, preventing the progression into late-stage cell death. Beclin-
1 up-regulation was due to proteasomal degradation, in which Herp
and Hrd1 are involved. The results from this study led us to propose
that modulation of Herp levels—by depletion or possibly inhibition—
may represent an early point of intervention in favor of the phase of
the ER stress response associated to autophagy. In our model, Herp is
upstream of Beclin-1, where it controls proteasomal degradation of
ERAD substrates as well as Beclin-1. However, in the absence of
Herp, Beclin-1 is stabilized and up-regulates the autophagic response
(a proposed model is presented in Fig. 6).
Herp is an ER stress-induced protein. Accordingly, we conﬁrmed
that Herp expression depends on IRE1α as described before [28].
However, it is also known that herp is a target gene of other UPR
signaling branches mediated by ATF6 [29] and ATF4 [30]. Herp
expression was initially suggested to play an important role in
protecting cells against ER stress. According to Chan et al., siRNA-
mediated depletion of Herp increased neuron sensitivity to ER stress
induced apoptosis, while overexpression of Herp prevented apoptosis
[15]. Similarly, Hori et al. evaluated cell viability in Herp knockout F9
embryonic carcinoma cells [16]. Absence of Herp increased cell
susceptibility to ER stress induced cell death [16]. Our results support
a new biological function of Herp that signiﬁcantly impacts cellular
homeostasis, where Herp depletion increases autophagic ﬂux. This
activity of Herp enhances the clearance of abnormal poly-Ub proteins
in the cytoplasm and the nucleus. Other researchers have previously
mentioned the cytoprotector effect of Herp on ER stress, however
most of the work that links Herp with cellular protection has been
done in neuronal models [9,21,31,32]. In this context, our work
strengthens the idea that the role of Herp as a stress-responsive gene
depends on the model and stimuli used. Because Herp levels are not
particularly high in the brain, it would be interesting in future research
to determine the effect of Herp in other tissues with differential
expression such as the liver, pancreas or the kidneys [21], or in tissues
with higher levels of Herp, such as the heart, skeletal muscle or placenta[33]. As an example, a recent report using Herp deﬁcient animals
evidenced a new function of Herp in the liver, where it modulates
glucose tolerance, and this may have an important impact in models
of diabetes and obesity [21].
At a mechanistic level, we showed that Herp expression
negatively modulated the levels of Beclin-1 and Atg5, two essen-
tial autophagy regulators. Particularly, Herp mediates Beclin-1
proteasomal degradation through the regulation of the E3 ubiquitin
ligase Hrd1. Recently, other researchers have described Beclin-1 Lys
11-linked poly-ubiquitination and proteasomal degradation through
the E3 ubiquitin ligase NEDD4 [34]. Herp interacts with various E3
ubiquitin ligases such as POSH, SIAH1a and Hrd1 [13,17,35].
Whether Herp interacts with other ubiquitin ligases than Hrd1 to
regulate Beclin-1 ubiquitination remains to be elucidated. A large
set of evidence links Herp with the ERAD pathway, which is
activated by the UPR through the transcription of the target genes
herp, edem among others [28]. This is because Herp plays an active
role in proteasomal degradation by its association with Hrd1,
Derlin1, VIMP, p97 and ubiquilins [11,12]. Conversely, Herp absence
increases the half-life of several proteins including connexin-43,
CD3δ, interleukins IL-12/IL-23 and light chain κ [11,14,16,36].
Importantly, several different reports describe interactions between
the ERAD pathway and the autophagy-lysosomal system, however
the mechanism underlying this cross-talk is not well understood
[37,38]. Some studies propose a balance between both degradative
pathways, in which both can alternatively target substrate proteins
[8,39–41]. Our data support this concept, suggesting that Herp
is an important mediator of the crosstalk between ERAD and
autophagy, where autophagy is activated as an alternative
mechanism to remove poly-Ub aggregates independently of the
proteasome. In agreement with this, we previously reported that
targeting the UPR transcription factor XBP1 leads to ERAD
3303C. Quiroga et al. / Biochimica et Biophysica Acta 1833 (2013) 3295–3305impairment, resulting in increased autophagy [42], and this is
possibly due to downregulation of EDEM1 [9]. Interestingly, we
showed that XBP1 also controls Herp levels, suggesting that Herp
may contribute to the up-regulation of autophagy when the UPR
is impaired [9]. In a different setting of muscular dystrophy,
native dysferlin was degraded via ERAD, while the mutant form
spontaneously aggregated in the ER, inducing autophagic ﬂux that
was essential for its degradation [8]. In addition, the concerted
activation of the ERAD and autophagic pathways can allow the
elimination of misfolded procollagen [39,43] and accumulated
mutant ﬁbrinogen [41]. Autophagy also contributes to the deg-
radation of toxic polymers of neuroserpin and α1-antitripsin when
ERAD is inhibited [44]. These studies suggest an emerging scenario
where autophagy may balance ERAD impairment to maintain
protein homeostasis [45].
An alternative scenario can be based on the ﬁndings that autophagic
degradation of the ER, or “ER-phagy”, is essential to eliminate damaged
portions of ER [46]. The double role of Herp promoting the ERAD
pathway and inhibiting autophagy may have important implications
in the transition between these two mechanisms. Herp is a protein
with a relatively short half-life of 2.5 h [25]. In this context, the fact
that we observed an up-regulation of Herp during early ER stress
could be related to an early inhibition of ER-phagy, allowing to develop
a restorative ERADpathway and tomaintain ER homeostasis. If ER stress
becomes chronic, autophagy can take over for degradation of damaged
ER. This hypothesis can also explain our results where we observe that
Herp-deﬁcient cells are able to initiate autophagy earlier than control
cells, allowing the clearance of chemically induced accumulation of
poly-Ub proteins and protecting from cell death. We speculate that
Herp could be an early timing signal in the transition from restorative
UPR to unbalanced UPR,where pro-apoptoticmechanisms are activated
due to unbalanced ER stress.
In conclusion, we propose that Herp can act as an autophagy
repressor besides its role in the ERADpathway. Herp therefore, operates
as a stress integrator on an intermediate point in the crosstalk between
the ERAD and the autophagic degradation systems. Due to the known
role of Herp in ischemic and neurodegenerative diseases, this study
may have important applications to understand the role of Herp in
pathological conditions involving altered metabolism and protein
homeostasis.Conﬂict of interest
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